BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36087860)

  • 1. Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening.
    Vachani A; Carroll NM; Simoff MJ; Neslund-Dudas C; Honda S; Greenlee RT; Rendle KA; Burnett-Hartman A; Ritzwoller DP
    J Thorac Oncol; 2022 Dec; 17(12):1355-1364. PubMed ID: 36087860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Computed Tomographic Screening Promotion With Lung Cancer Overdiagnosis Among Asian Women.
    Gao W; Wen CP; Wu A; Welch HG
    JAMA Intern Med; 2022 Mar; 182(3):283-290. PubMed ID: 35040922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Introduction of Low-Dose CT Imaging and Lung Cancer Overdiagnosis in Chinese Women.
    Wang M; Lin S; He N; Yang C; Zhang R; Liu X; Suo C; Lin T; Chen H; Xu W
    Chest; 2023 Jan; 163(1):239-250. PubMed ID: 35998705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of low-dose computed tomography screening on lung cancer incidence and outcomes.
    Vachani A; Caruso C
    Curr Opin Pulm Med; 2023 Jul; 29(4):232-238. PubMed ID: 37191171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study.
    Kim RY; Rendle KA; Mitra N; Saia CA; Neslund-Dudas C; Greenlee RT; Burnett-Hartman AN; Honda SA; Simoff MJ; Schapira MM; Croswell JM; Meza R; Ritzwoller DP; Vachani A
    Ann Am Thorac Soc; 2022 Sep; 19(9):1561-1569. PubMed ID: 35167781
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
    Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
    Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
    Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
    J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
    Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
    Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study.
    Braithwaite D; Karanth SD; Slatore CG; Zhang D; Bian J; Meza R; Jeon J; Tammemagi M; Schabath M; Wheeler M; Guo Y; Hochhegger B; Kaye FJ; Silvestri GA; Gould MK
    BMJ Open; 2022 Jun; 12(6):e064142. PubMed ID: 35732383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration.
    Lillie SE; Fu SS; Fabbrini AE; Rice KL; Clothier B; Nelson DB; Doro EA; Moughrabieh MA; Partin MR
    Lung Cancer; 2017 Feb; 104():38-44. PubMed ID: 28212998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study.
    Rendle KA; Saia CA; Vachani A; Burnett-Hartman AN; Doria-Rose VP; Beucker S; Neslund-Dudas C; Oshiro C; Kim RY; Elston-Lafata J; Honda SA; Ritzwoller D; Wainwright JV; Mitra N; Greenlee RT
    Ann Intern Med; 2024 Jan; 177(1):18-28. PubMed ID: 38163370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timely adherence to follow-up after high-risk lung cancer screenings.
    Kee D; Sigel KM; Wisnivesky JP; Kale MS
    J Med Screen; 2023 Sep; 30(3):150-155. PubMed ID: 36916158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
    Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
    Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions and Utilization of Lung Cancer Screening Among Primary Care Physicians.
    Raz DJ; Wu GX; Consunji M; Nelson R; Sun C; Erhunmwunsee L; Ferrell B; Sun V; Kim JY
    J Thorac Oncol; 2016 Nov; 11(11):1856-1862. PubMed ID: 27346412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delays in Recommended Follow-Up after Positive Findings in Lung Cancer Screening.
    Ahmed A; Hippe DS; Snidarich M; Crothers K; Triplette M
    Ann Am Thorac Soc; 2023 Aug; 20(8):1175-1181. PubMed ID: 36973008
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient Adherence to Screening for Lung Cancer in the US: A Systematic Review and Meta-analysis.
    Lopez-Olivo MA; Maki KG; Choi NJ; Hoffman RM; Shih YT; Lowenstein LM; Hicklen RS; Volk RJ
    JAMA Netw Open; 2020 Nov; 3(11):e2025102. PubMed ID: 33196807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the National Lung Screening Trial (NLST) publication and Medicare Lung cancer screening payment on lung cancer incidence rates: An interrupted time series analysis.
    Emmerick ICM; Uy K; Guiab K; Powers M; Lou F; Lin P; Maxfield M; Voland R; Varlotto J
    J Cancer Policy; 2022 Mar; 31():100318. PubMed ID: 35559870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.